In 2026, Malaysia's pharmaceutical market reached a value of 8 $, securing the 193-th position out of 197 countries. This figure cements the nation's role as a major pharmaceutical hub in Southeast Asia. Market expansion is driven by a robust generic drug manufacturing sector, rising public healthcare expenditure, and an aging demographic profile. The industrial heartland lies in the states of Penang and Selangor, which host a dense concentration of production facilities operated by both domestic firms and global pharmaceutical giants.
Malaysia world ranking
Country position on the scale from last to first place for this indicator.
Change over time
Change in indicator over the available period.
Values — $
Top countries by Pharmaceutical market size
Where Malaysia stands in the world ranking.
People also search for
Other pages of the reference by this indicator.